Goto

Collaborating Authors

 isct


Interpretable Sequence Clustering

arXiv.org Artificial Intelligence

Categorical sequence clustering plays a crucial role in various fields, but the lack of interpretability in cluster assignments poses significant challenges. Sequences inherently lack explicit features, and existing sequence clustering algorithms heavily rely on complex representations, making it difficult to explain their results. To address this issue, we propose a method called Interpretable Sequence Clustering Tree (ISCT), which combines sequential patterns with a concise and interpretable tree structure. ISCT leverages k-1 patterns to generate k leaf nodes, corresponding to k clusters, which provides an intuitive explanation on how each cluster is formed. More precisely, ISCT first projects sequences into random subspaces and then utilizes the k-means algorithm to obtain high-quality initial cluster assignments. Subsequently, it constructs a pattern-based decision tree using a boosting-based construction strategy in which sequences are re-projected and re-clustered at each node before mining the top-1 discriminative splitting pattern. Experimental results on 14 real-world data sets demonstrate that our proposed method provides an interpretable tree structure while delivering fast and accurate cluster assignments.


Optimal personalised treatment computation through in silico clinical trials on patient digital twins

arXiv.org Artificial Intelligence

In Silico Clinical Trials (ISCT), i.e., clinical experimental campaigns carried out by means of computer simulations, hold the promise to decrease time and cost for the safety and efficacy assessment of pharmacological treatments, reduce the need for animal and human testing, and enable precision medicine. In this paper we present methods and an algorithm that, by means of extensive computer simulation-based experimental campaigns (ISCT) guided by intelligent search, optimise a pharmacological treatment for an individual patient (precision medicine). We show the effectiveness of our approach on a case study involving a real pharmacological treatment, namely the downregulation phase of a complex clinical protocol for assisted reproduction in humans.